98 related articles for article (PubMed ID: 20320131)
1. Is Cardiovascular-Renal Disease Increasing as a Cause of Death in Canada?
Macklin MT
Can Med Assoc J; 1936 Jan; 34(1):56-64. PubMed ID: 20320131
[No Abstract] [Full Text] [Related]
2. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database.
Barco S; Valerio L; Ageno W; Cohen AT; Goldhaber SZ; Hunt BJ; Iorio A; Jimenez D; Klok FA; Kucher N; Mahmoudpour SH; Middeldorp S; Münzel T; Tagalakis V; Wendelboe AM; Konstantinides SV
Lancet Respir Med; 2021 Jan; 9(1):33-42. PubMed ID: 33058771
[TBL] [Abstract][Full Text] [Related]
3. Cause of Death in Patients with Reduced Kidney Function.
Thompson S; James M; Wiebe N; Hemmelgarn B; Manns B; Klarenbach S; Tonelli M;
J Am Soc Nephrol; 2015 Oct; 26(10):2504-11. PubMed ID: 25733525
[TBL] [Abstract][Full Text] [Related]
4. Mortality from Alzheimer's disease in Canada: A multiple-cause-of-death analysis, 2004 to 2011.
Park J
Health Rep; 2016 May; 27(5):17-21. PubMed ID: 27192207
[TBL] [Abstract][Full Text] [Related]
5. The current status of cardiovascular disease in Canada--a call to action.
Svendsen A
Can J Cardiovasc Nurs; 2004; 14(1):5-7. PubMed ID: 15022527
[TBL] [Abstract][Full Text] [Related]
6. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure.
Hoy WE; Wang Z; VanBuynder P; Baker PR; McDonald SM; Mathews JD
Kidney Int; 2001 Jul; 60(1):249-56. PubMed ID: 11422758
[TBL] [Abstract][Full Text] [Related]
7. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial.
Carson JL; Sieber F; Cook DR; Hoover DR; Noveck H; Chaitman BR; Fleisher L; Beaupre L; Macaulay W; Rhoads GG; Paris B; Zagorin A; Sanders DW; Zakriya KJ; Magaziner J
Lancet; 2015 Mar; 385(9974):1183-9. PubMed ID: 25499165
[TBL] [Abstract][Full Text] [Related]
8. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation.
Meier-Kriesche HU; Baliga R; Kaplan B
Transplantation; 2003 Apr; 75(8):1291-5. PubMed ID: 12717218
[TBL] [Abstract][Full Text] [Related]
9. Mortality differentials between three populations--residents of Scandinavia, Scandinavian immigrants to Canada and Canadian-born residents of Canada, 1979-1985.
Valkonen T; Brancker A; Reijo M
Health Rep; 1992; 4(2):137-59. PubMed ID: 1421018
[TBL] [Abstract][Full Text] [Related]
10. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
[TBL] [Abstract][Full Text] [Related]
11. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.
Churchill DN; Thorpe KE; Vonesh EF; Keshaviah PR
J Am Soc Nephrol; 1997 Jun; 8(6):965-71. PubMed ID: 9189865
[TBL] [Abstract][Full Text] [Related]
12. Regional variations in cardiovascular mortality in Canada.
Filate WA; Johansen HL; Kennedy CC; Tu JV
Can J Cardiol; 2003 Oct; 19(11):1241-8. PubMed ID: 14571309
[TBL] [Abstract][Full Text] [Related]
13. Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.
Soveri I; Holdaas H; Jardine A; Gimpelewicz C; Staffler B; Fellström B
Nephrol Dial Transplant; 2006 Aug; 21(8):2282-9. PubMed ID: 16574686
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Autonomic Neuropathy and its Association with Cardiovascular and All-cause Mortality in Patients with End-stage Renal Disease.
Bokhari SRA; Inayat F; Jawa A; Virk HUH; Awais M; Hussain N; Hassan GU; Ahmad HI; Chaudhry HS; Adil A; Haider A; Figueredo VM; Rangaswami J; Assir MZK
Cureus; 2018 Aug; 10(8):e3243. PubMed ID: 30410849
[TBL] [Abstract][Full Text] [Related]
15. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
O'Shaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Eur Heart J; 2019 Mar; 40(11):887-898. PubMed ID: 30085056
[TBL] [Abstract][Full Text] [Related]
16. Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand.
LeLorier J; Rawson NS
Can J Cardiol; 2007 Jul; 23(9):711-8. PubMed ID: 17622393
[TBL] [Abstract][Full Text] [Related]
17. Burden of cardiovascular disease in Canada.
Manuel DG; Leung M; Nguyen K; Tanuseputro P; Johansen H;
Can J Cardiol; 2003 Aug; 19(9):997-1004. PubMed ID: 12915926
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
Odutayo A; Wong CX; Hsiao AJ; Hopewell S; Altman DG; Emdin CA
BMJ; 2016 Sep; 354():i4482. PubMed ID: 27599725
[TBL] [Abstract][Full Text] [Related]
19. The State of Affairs for Cardiovascular Health Research in Indigenous Women in Canada: A Scoping Review.
Prince SA; McDonnell LA; Turek MA; Visintini S; Nahwegahbow A; Kandasamy S; Sun LY; Coutinho T
Can J Cardiol; 2018 Apr; 34(4):437-449. PubMed ID: 29439893
[TBL] [Abstract][Full Text] [Related]
20. Theoretical rationale of community intervention for the prevention and control of cardiovascular disease.
MacLean DR
Health Rep; 1994; 6(1):174-80. PubMed ID: 7919078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
